Results and Discussion An unidentified
Gram-negative bacteria, K-341-B7, was found to produce a new antibiotic complex, Bu-2841. The antibiotic complexwas isolated from whole broth by chromatography on silica gel and Sephadex LH-20. HPLC analysis showed that the complex was composed of at least ten components. Four components, Bu-2841-02, -04, -08, and -10, were isolated from the complex and purified by reversed phase HPLC. Chemical characterization of the components indicated that they were peptides. Although the four antibiotics isolated here behaved as a single entity under all conditions tested for HPLC, their NMRspectra indicated that Bu-2840-08 and -10 were a mixture of three or four homologouscomponents, and the others were mixtures of more than four peptides. In this paper, we will describe the isolation, structures and biological properties of Bu-2841-08 and -10. Isolation and Purification A flow diagram for the isolation procedure is given in a residue. The residue was dissolved in a small amount of methanol and subjected to a silica gel column subsequently eluted with methanol and aqueous methanol.
Active fractions were further purified by a Sephadex LH-20 column eluted with aqueous acetonitrile. The antibiotic complex was obtained as a colorless powder. An analytical HPLC chromatogram of the complex showed that it consisted of at least ten components designated as Bu-2841-01~Bu-2841-10. Amino acid analysis of the complex after hydrolysis with 6n HC1 and optical rotations of these amino acids (Table 1) suggested that the main peptides contained D-aspartic acid (2eq.), L-aspartic acid (1 eq.), L-threonine (1 eq.), D-serine (l eq.), glycine (2eq.), L-isoleucine (1 eq.), lphenylalanine (1 eq.), D-2,4-diaminobutyric acid (1 eq.), and L-2,4-diaminobutyric acid (1 eq.)1}. UV spectrum of the complex also indicated the presence of a tryptophan residue in the antibiotics (UV Amax: 205, 240 (sh) , 274, 281, 290 nm). GC-MSofmethyl esters of the fatty acids which were obtained by hydrolysis of the antibiotic complex suggested that the acyl group consisted of more than ten /Miydroxylfatty acids (C8~C12) and normal fatty acids. In order to isolate each component, the complex was subjected to a reversed phase HPLCunder straight-chain carboxylic acid), 0.85 (d, anteiso carboxylic acid), and 0.86 (t, anteiso carboxylic acid). By a peak height comparison of the triplet signals of the anteiso carboxylic acid and the methyl signal of the isoleucine, the ratio of anteiso carboxylic acid to straight-chain isomer was calculated to be about 4 : 1. The structures of the /?-hydroxylcarboxylic acid residues were confirmed The region between 3 0.7-0.92 (400MHz, 60°C). (C2), 67.5 (C3)3). The minor acyl group (C1X) was not detected in the spectrum of 1. On the other hand, the ratio of an anteiso carboxylic acid to straight-chain isomer (Cn) of Bu-2841-10 (2) was about 4:1 as described in next subsection, from which the ratio of the minor carboxylic acid residues (CX1) of 1 may be same as that of main acyl groups of 2. The presence of an intramolecular ester linkage was found by hydrolysis of 1 with tris-buffer (pH 8.5) at 40°C. In the XH NMR spectrum of the hydrolysate (la, m/z 1481 (M+H)+), j8-proton signal of threonine (S 4.07 (m)) appeared at more up field than that of 1, while those of serine and the acyl group were observed at almost same region of those of 1. Noinformation for the structure was obtained from the FAB-MSof 1 except the molecular weight. Positive ion FAB-MS/MSof quasi-molecular ion (2 x Asp))+, etc. However, the spectrum did not give any ion peaks from cleavage of the cyclic peptide chain (cleavages of peptide bond or ester bond and between a-carbon and amino or carbonyl group). The above data indicated that the C-terminal amino acid is linked by an ester bond to the threonine residue and that the y-amino group of 2,4-diaminobutyric acids and the y-carbonyl group of aspartic acids did not form a peptide bond. The amino acid sequence of la was determined by the positive ion FAB-MS/MSof its #wos7-molecular ion ((M +H)+) except for the sequence of glycine and asparagine (Fig.  3)4) . The fifth and sixth residues were determined with rotating frame NOEspectroscopy (ROESY) spectrum as glycine and asparagine, respectively, as shown in Amino acid analysis of2 gave the same result as 1 except a ratio of isoleucine (0.9eq.) to valine (0.1 eq.). In XH NMRspectrum of 2, the chemical shifts and coupling patterns of the amino acid residues were similar to those of 1 (Table 3 ). These data suggested that the structure of cyclic peptide moiety is identical with that of 1, and the sequence of amino acids and acyl group was confirmed with NOESY spectrum of2. The structures ofacyl groups (CUH21O2) were determined by /-resolved 2D spectrum as 3-hydroxy-8-methyldecanoic acid and 3-hydroxyundecanoic acid (the ratio was about 4:1).
In the 13C
NMRspectrum of 2, the carbon signals of 3-hydroxy-8-methyldecanoic acid moiety were observed at 3 10.6 (C10, Me), 18.9 (Cll, Me), 26.4 (C5), 28.7 (C6), 33.5 (C9), 35.8 (C7), 36.8 (C4), 42.4 (C8), 43.2 (C2), 67.5 (C3), but those of 3-hydroxyundecanoic moiety were not detected. From these data, 2 was determined to have the same core peptide as 1 but different acyl groups. The stereochemistry of amino acid residues (residue-3, -4, -6, -7, -9, and -ll) was determined by the NOEdata Coupling constants in Hz.
2,4-diaminobutyric acid. The assignments may be exchanged with corresponding carbons of same amino acid residue.
( Fig. 5 ) and an examination of molecular models considered from observed intramolecular hydrogenbonds. The hydrogen-bonds were found for the amide NHprotons of 2,4-diaminobutyric acid-3 and tryptophan-9 with *H NMRmeasurements of 2 at various temperatures (Table 4 )5). By comparison of the spectra measured at 40°C and 60°C, the shifts of these amide NH protons were negligible (0~0.03 ppm), while those of other amide NH protons were 0.08~0.13ppm. On the other hand, NOEswere observed between the amide NHproton of aspartic acid-4 and a-proton of the other aspartic acid-7 and between the a-protons of glycine-8 and phenylalanine-12 in the NOESYspectrum of 2 (Fig.  5 ). These data indicated that the hydrogen-bonds exist between the amide NHproton of 2,4-diaminobutyric acid-3 and the carbonyl oxygen of aspartic acid-7 and between the amide NHproton of tryptophan-9 and the carbonyl oxygen of 2,4-diaminobutyric acid-1 1. NOE was also observed between the jS-proton of L-isoleucine-10 and /?-protons (S 1.87) of2,4-diaminobutyric acid-1 1. A nearest distance between these /^-protons is calculated to be 3.4 A when the 2,4-diaminobutyric acid-1 1 is L-form and 6.1 A when it is D-form in the molecular models. Therefore, 2,4-diaminobutyric acid-1 1 was determined as L-form, and consequently the other 2,4-diaminobutyric acid-3 is D-form. The assignment was confirmed by the NOE observed between the a-proton of 2,4-diaminobutyric acid-3 and the jS-proton of L-phenylalanine-12 (nearest distance between the protons of lphenylalanine-12 and D-2,4-diaminobutyric acid-3 is 1.9A, and that between L-phenylalanine-12 and l-2,4-diaminobutyric acid-3 is 4.8A).
The NOE between a These protons were assigned with COSYspectra.
y-proton(s) of D-2,4-diaminobutyric acid-3 and the jS-proton of aspartic acid-4 (<5 2.59) was also observed. The nearest distance between the two protons is 2.6A
(the residue-4 is L-form) and 3.8A (the residue-4 is D-form). Therefore, the residue -4 is L-aspartic acid and consequently the other aspartic acid-7 and asparagine-6 are D-forms. The observed NOEbetween an aromatic proton of tryptophan residue (C-5'-H) and the y-amide NH2 protons of the D-asparagine-6 indicated that tryptophan-9 is L-form (the nearest distance between these protons is 1.5 A (D-asparagine-6 and L-tryptophan-9) and 10.2 A (D-asparagine-6 and d-tryptophan-9)). To summarize these data, the structure of Bu-2841-08 (1) and -10 (2) were determined as shown in Fig. 6 . Previously, Shoji and Kato reported the structure of brevistin (3)6), a cyclic depsipeptide. The structure closely resembled those of the Bu-2841-08 (1) and -10 (2) reported here. However, significant differences reside in the amino acid contents and the acyl groups of brevistin and Bu-284
Antimicrobial Activity MICsof the antibiotics were determined by meansof a two-fold serial agar dilution method in Mueller-Hinton media for the bacteria, in Sabouraud media for fungi, and in yeast morphology media for yeast. The antibacterial and antifungal spectra are given in Table 5 . by activating the ions in the third field free region by collision with argon gas. GC-MSwas recorded on a Shimadzu LKB-9000 apparatus using an OV-17 column with temperature programing of 5°C/minute from 100°C. NMRspectra were recorded on a Jeol JNM-EX400
(400MHz for XH and 100MHz for 13C) or a Jeol JNM-a-500 (500MHz for XH and 125MHz for 13C) spectrometer. As *H NMRchemical shift reference, the center signal of DMSO-d6at 8 2.50, and as 13C NMR reference, the methyl signal of DMSO-<i6 at 5 39.5 ppm were used. Aminoacid analyses were performed with a Hitachi amino acid autoanalyzer model L-8500. UV spectra were recorded on a Shimadzu UV-265spec-trophotometer. Optical rotations were determined with a Jasco model DIP 140. For the examination with molecular models, Maruzen Biochemistry Molecular Model (peptide model) was used.
Acid Hydrolysis of Antibiotics A solution of Bu-2841 complex (1.2mg) in 0.5ml of 6n HC1was heated at 110°C for 24 hours in a vacuumsealed tube. The hydrolysate, after concentration to dryness in vacuo on a water-bath at 60°C, was dissolved in 0.02n HC1to 1.2ml and 10fA of the solution was analyzed with the amino acid analyzer (Table 1) . A mixture of each isolated peptides (0.2~0.6mg), 6n HC1 (0.5 ml), and thioglycolic acid (50 jal) was heated at 110°C for 24 hours in a vacuum-sealed tube. The hydrolysate, after treatment of the usual manner, was analyzed with the amino acid analyzer. The results were given in Table 2 .
In order to determine the constituent fatty acids and the chirality of amino acids, a mixture of Bu-2841 > 100.00 MOO complex (1.0g), 6n HC1 (42ml), and thioglycolic acid (1.8ml) was heated at 110°C for 17 hours in a vacuumsealed tube. The reaction mixture was extracted with ethyl ether. Evaporation of the ether extract afforded an oily residue. The aqueous layer was concentrated in vacuo to a residue which was chromatographed on a column of Dowex 50Wx4 (H+ form, 2x52cm) de-veloping with an increasing concentration of HC1 (0.05 -2.0 n). Appropriate fractions (Asp (120 mg); eluted with H2O, Asp, Ser, Thr (331 mg) with 0.2n HC1, Val (24mg) with 0.3n HC1, He (77mg) with 0.4n HC1, Phe (137mg) with 0.5n HC1, 2,4-Dab (229mg) with 0.7n HC1)) were pooled and concentrated under reduced pressure. The aminoacids were further purified with columnchromatography on Amberlite IRA-400 (Cl" form) and XAD-2, eluted with H2O, to give aspartic acid (203 mg), glycine (1 15 mg), valine (22mg), isoleucine (72mg), phenylalanine (1 17mg), and 2,4-diaminobutyric acid (218 mg) as hydrochlorides.
Threonine hydrochloride (72 mg) and serine hydrochloride (52 mg) were isolated by preparative TLC (Avicel, developer; BuOH-AcOH-H2O (8 : 1 : 1)) and column chromatography on Amberlite IRA-400 (Cl~form, H2O). A part of the oily residue obtained from the above ethereal extract was treated with diazomethane in ethereal solution. After evaporation of the solvent, the residue was analyzed by the GC-MS spectrometer.
